Antibiotic prescriptions in acute otitis media and pharyngitis in Italian pediatric outpatients.

E Barbieri, D Donà, A Cantarutti, R Lundin, A Scamarcia, G Corrao, L Cantarutti, C Giaquinto
Author Information
  1. E Barbieri: Department for Woman and Child Health, University of Padua, Padua, Italy. elisa.barbieri.5@phd.unipd.it. ORCID
  2. D Donà: Division of Paediatric Infectious Diseases, Department for Woman and Child Health, University of Padua, Via Giustiniani 3, 35141, Padua, Italy.
  3. A Cantarutti: National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
  4. R Lundin: PENTA Foundation, Padua, Italy.
  5. A Scamarcia: Pedianet Project, Padua, Italy.
  6. G Corrao: National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
  7. L Cantarutti: Pedianet Project, Padua, Italy.
  8. C Giaquinto: Division of Paediatric Infectious Diseases, Department for Woman and Child Health, University of Padua, Via Giustiniani 3, 35141, Padua, Italy.

Abstract

BACKGROUND: Acute otitis media (AOM) and pharyngitis are very common infections in children and adolescents. Italy is one of the European countries with the highest rate of antibiotic prescriptions. The aim of this study is to describe first-line treatment approaches for AOM and pharyngitis in primary care settings in Italy over six years, including the prevalence of 'wait and see' for AOM, where prescription of antibiotics is delayed 48 h from presentation, and differences in prescribing for pharyngitis when diagnostic tests are used.
METHODS: The study is a secondary data analysis using Pedianet, a database including data at outpatient level from children aged 0-14 in Italy. Prescriptions per antibiotic group, per age group and per calendar year were described as percentages. "Wait and see" approach rate was described for AOM and pharyngitis prescriptions were further grouped according to the diagnostic test performed and test results.
RESULTS: We identified 120,338 children followed by 125 family pediatricians between January 2010 and December 2015 for a total of 923,780 person-years of follow-up. Among them 30,394 (mean age 44 months) had at least one AOM diagnosis (n = 54,943) and 52,341 (mean age 5 years) had at least one pharyngitis diagnosis (n = 126,098). 82.5% of AOM diagnoses were treated with an antibiotic within 48 h (mainly amoxicillin and amoxicillin/clavulanate) and the "wait and see" approach was adopted only in 17.5% of cases. The trend over time shows an increase in broad spectrum antibiotic prescriptions in the last year (2015). 79,620 (63%) cases of pharyngitis were treated and among GABHS pharyngitis confirmed by rapid test 56% were treated with amoxicillin. The ones not test confirmed were treated mainly with broad spectrum antibiotics.
CONCLUSIONS: Despite guidance to use the 'wait and see' approach in the age group analyzed, this strategy is not often used for AOM, as previously noted in other studies in hospital settings. Broad-spectrum antibiotic prescription was more frequent when pharyngitis was not confirmed by rapid test, in keeping with evidence from other studies that diagnostic uncertainty leads to overuse of antibiotics.

Keywords

References

  1. Pediatrics. 1999 Dec;104(6):1384-8 [PMID: 10585992]
  2. BMJ. 2001 Feb 10;322(7282):336-42 [PMID: 11159657]
  3. Clin Microbiol Infect. 2001;7 Suppl 6:12-5 [PMID: 11990686]
  4. JAMA. 2002 Jun 19;287(23):3133-5 [PMID: 12069678]
  5. Ann Ig. 2002 Jul-Aug;14(4 Suppl 6):21-7 [PMID: 12389301]
  6. Arch Intern Med. 2003 Apr 28;163(8):972-8 [PMID: 12719208]
  7. Clin Microbiol Infect. 2003 Dec;9(12):1162-78 [PMID: 14686981]
  8. Infection. 2003 Dec;31(6):398-403 [PMID: 14735382]
  9. Pediatr Infect Dis J. 1992 Aug;11(8 Suppl):S7-11 [PMID: 1513611]
  10. Eur J Pediatr. 2005 Jan;164(1):1-2 [PMID: 15549377]
  11. J Hosp Infect. 2007 Aug;66(4):378-84 [PMID: 17573155]
  12. Eur J Clin Pharmacol. 2007 Dec;63(12):1099-106 [PMID: 17891535]
  13. Acad Emerg Med. 2007 Dec;14(12):1172-5 [PMID: 18045893]
  14. J Antimicrob Chemother. 2008 Apr;61(4):953-8 [PMID: 18218639]
  15. Int J Antimicrob Agents. 2008 May;31(5):478-83 [PMID: 18343641]
  16. J Hosp Infect. 2008 Apr;68(4):372-4 [PMID: 18353500]
  17. Eur J Pediatr. 2009 Jun;168(6):667-72 [PMID: 18762979]
  18. Evid Based Nurs. 2009 Apr;12(2):39-40 [PMID: 19321817]
  19. Eur J Clin Pharmacol. 2009 Aug;65(8):749-55 [PMID: 19529926]
  20. BMC Pediatr. 2009 Nov 06;9:69 [PMID: 19895678]
  21. Pediatrics. 2010 Sep;126(3):e557-64 [PMID: 20696723]
  22. Pediatrics. 2010 Dec;126(6):1067-73 [PMID: 21078728]
  23. Arch Dis Child. 2011 Jun;96(6):590-5 [PMID: 21233078]
  24. Ital J Pediatr. 2011 Jan 31;37:10 [PMID: 21281502]
  25. PLoS One. 2012;7(4):e36226 [PMID: 22558393]
  26. BMC Pediatr. 2012 Nov 29;12:185 [PMID: 23190626]
  27. JAMA. 2013 Jun 12;309(22):2345-52 [PMID: 23757082]
  28. J Antimicrob Chemother. 2013 Nov;68(11):2421-3 [PMID: 24027247]
  29. Drug Saf. 2013 Oct;36 Suppl 1:S159-69 [PMID: 24166232]
  30. Pak J Med Sci. 2013 Sep;29(5):1167-72 [PMID: 24353713]
  31. Expert Rev Anti Infect Ther. 2014 Sep;12(9):1159-63 [PMID: 25075863]
  32. Infect Control Hosp Epidemiol. 2014 Oct;35 Suppl 3:S79-85 [PMID: 25222902]
  33. Pediatrics. 2014 Oct;134(4):e956-65 [PMID: 25225144]
  34. Ital J Pediatr. 2015 May 07;41:37 [PMID: 25948496]
  35. PLoS One. 2015 Sep 25;10(9):e0139097 [PMID: 26405817]
  36. Int J Pediatr. 2016;2016:5236243 [PMID: 26884770]
  37. Infect Control Hosp Epidemiol. 2016 Jul;37(7):852-4 [PMID: 27020133]
  38. PLoS One. 2016 May 16;11(5):e0154662 [PMID: 27182926]
  39. Pediatr Infect Dis J. 2016 Dec;35(12):1317-1323 [PMID: 27626915]
  40. PLoS One. 2018 Feb 28;13(2):e0193581 [PMID: 29489898]
  41. Pediatr Infect Dis J. 2018 Sep;37(9):901-907 [PMID: 29561517]
  42. BMJ Paediatr Open. 2017 Sep 11;1(1):e000169 [PMID: 29637165]
  43. JAMA. 1998 Mar 18;279(11):875-7 [PMID: 9516004]
  44. Int J Antimicrob Agents. 1998 May;10(2):161-4 [PMID: 9716293]

MeSH Term

Acute Disease
Anti-Bacterial Agents
Child
Child, Preschool
Female
Humans
Infant
Italy
Male
Otitis Media
Outpatients
Practice Patterns, Physicians'
Retrospective Studies

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0pharyngitisAOMantibiotictestprescriptionsagetreatedotitischildrenItalyoneantibioticsdiagnosticpergroupapproachconfirmedmediaratestudysettingsincluding'waitsee'prescription48 huseddatayeardescribedsee"2015meanleastdiagnosis5%mainlyamoxicillincasesbroadspectrumrapidstudiesBACKGROUND:AcutecommoninfectionsadolescentsEuropeancountrieshighestaimdescribefirst-linetreatmentapproachesprimarycaresixyearsprevalencedelayedpresentationdifferencesprescribingtestsMETHODS:secondaryanalysisusingPedianetdatabaseoutpatientlevelaged0-14Prescriptionscalendarpercentages"WaitgroupedaccordingperformedresultsRESULTS:identified120338followed125familypediatriciansJanuary2010Decembertotal923780person-yearsfollow-upAmong3039444 monthsn = 54943523415 yearsn = 12609882diagnoseswithinamoxicillin/clavulanate"waitadopted17trendtimeshowsincreaselast7962063%amongGABHS56%onesCONCLUSIONS:DespiteguidanceuseanalyzedstrategyoftenpreviouslynotedhospitalBroad-spectrumfrequentkeepingevidenceuncertaintyleadsoveruseAntibioticacuteItalianpediatricoutpatients“Antibioticprescriptions”“Italianstudy”“Pediatricpatient”“Pharmacoepidemiology”“acutemedia”“pharyngitis”“waitsee”

Similar Articles

Cited By